First Financial Bankshares, Inc. (FFIN): what the price requires

At today's price, First Financial Bankshares, Inc. (FFIN) is priced for 19.4% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/FFIN

Headline

FieldValue
TickerFFIN
CompanyFirst Financial Bankshares, Inc.
Current price$34.73/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Price-to-book2.56x
Return on equity now13.2%

The implied return on book is non-physical at this price-to-book and is suppressed as misleading. The price sits beyond a 13.3% return on equity sustained for 40 years and is not resolvable as a sustainable-ROE point. The rarity read below is the honest signal.

Solve inputs: computed at a 10% cost of equity; ROE searched up to the 13.3% ROE ceiling.

How unusual the bet is: extreme

ReferenceValue
vs own history+10.00σ
cohort percentile (of 119 peers)95
sustained it ~10 years at this level52%
implied end-window share0%

Valuation X-Ray

The price is supported by earnings-power and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.47x3expensive
Earnings1.19x2expensive
Relative1.28x3expensive
Growth1.03x1expensive

Families that justify the price: Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$27.291.27xyesTBVPS $13.54 × 2.02x (ROE (TTM) 13.6% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$27.111.28xyesP/E 12.67x (blended: static sector reference 10x + trailing (TTM) 19x), scenarios: 10.4x / 12.7x / 15.0x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$19.861.75xyesBV/sh $13.54, ROE (TTM) 13.6%, ke 9.3%
Two-Stage Excess ReturnAsset$23.821.46xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$33.611.03xyesRev $0.5B, growth 16% (input: historical growth; tapered), Terminal P/S: 7.9x / 9.6x / 11.4x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$24.941.39xyesEPS $1.84, growth 14% (input: historical EPS growth), PEG=1.40 (Fair)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$23.671.47xyes√(22.5 × EPS $1.84 × BVPS $13.54) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$54.910.63xyesEPS $1.84 × (8.5 + 2×13.6%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$37.410.93xyesEPS $1.84 × (PEG 1.5 × growth 13.6% (input: historical EPS growth)) → PE 20.3x
Earnings YieldEarnings$19.891.75xyesEPS $1.84 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (dilution)0.1%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

The earnings line has been moving up steadily: Q1 2026 net income of $71.5 million and EPS of $0.50, up 16.6% year over year, with the net interest margin widening to 3.86% from 3.74% a year ago. Net interest income reached $134.8 million.

This is a premium bank earning a premium return, about 13.6% on equity against a 9.3% cost of equity, which is why the bank model values it at roughly two times tangible book.

The quality is real. Net charge-offs ran 0.02% annualized and nonperforming assets fell to 0.66% of loans. The stock trades on the durability of that record, so the risk is in the multiple, not the bank.

Bull Case

Follow the earnings trajectory, because it is the clearest part of the story. Net interest income rose to $134.8 million in Q1 2026 from $118.8 million a year earlier, the net interest margin widened to 3.86% on a tax-equivalent basis from 3.74%, and net income climbed 16.6% to $71.5 million with EPS of $0.50. That is not a one-quarter blip. The 10-K shows the margin expanding from 3.50% in 2024 to 3.79% in 2025, primarily as the asset mix shifted toward higher-yielding loans (accession 0001193125-26-071549). A bank whose core spread has widened three years running is compounding earnings in the most durable way a bank can.

The return on capital is what sets First Financial apart from the regional-bank field. It earns roughly 13.6% on equity against a 9.3% cost of equity, a spread wide enough that the bank-specific model values it at about two times tangible book rather than the one-times that an average bank earns. The credit record is the reason that premium is durable: Q1 annualized net charge-offs ran just 0.02% and nonperforming assets fell to 0.66% of loans, the kind of pristine underwriting that holds value when the cycle turns.

The balance sheet is scaling without straining. Total assets reached $15.4 billion at March 31, 2026, with loans held for investment of $8.3 billion and deposits of $13.2 billion, a deposit-heavy funding base that is exactly what kept the margin expanding while peers paid up for funding. The relative-valuation method lands near $26 on a blended P/E around 12x, the future-market-cap method reaches the price at $33, and the bank model itself sits at $27. For a franchise this consistent, paying a premium for proven returns in a growing Texas market is a defensible bet rather than a stretch.

Bear Case

Strip away the quality and what is left is a price that depends on the premium never fading, and that is the fragile assumption. That multiple is not a mistake; it is a bet that a 13.6% return on equity and a clean credit book persist indefinitely. The specific future this price requires is continued premium profitability and premium growth at the same time, and the most fragile piece is the margin: the entire recent earnings lift came from a net interest margin that expanded from 3.50% to 3.79% to 3.86%, and that expansion is a function of the rate environment as much as of management.

The valuation methods are unusually unanimous that the price runs ahead of the fundamentals. The simple excess-return method lands at $20, the earnings-yield method at $20, the bank tangible-book model at $27, and the relative method at $26, all below the price. The model-confidence read flags the implied expectations as high and outside the normal range against both the bank's own history and its peer cohort. When a premium name trades above where every value-anchored method places it, the upside has to come from the multiple expanding further, not from the business catching up, and multiples on banks compress quickly when sentiment turns.

The macro lever is the same one that helped: rates. The margin gains lean on a favorable funding environment, and if the Federal Reserve resumes cutting, a deposit-funded bank sees asset yields fall faster than it can re-price already-low-cost deposits, squeezing the spread that drives the narrative. A high-quality bank is still a bank, and a bank trading at two times book with the margin near a cyclical high is priced for the good environment to continue. The earnings trajectory is genuinely strong; the question the bear asks is what an investor pays for it, and at this multiple the answer is full.

Valuation

First Financial does not invert into a clean growth number because it is a financial, so the read is the return spread and the multiple it earns. The bank earns about 13.6% on equity against a 9.3% cost of equity, and that wide spread is why the tangible-book model assigns it roughly two times TBVPS of $13.54, landing at about $27. That is the value the franchise quality supports, and it sits below the current price near $33.

The surrounding methods point the same way. Relative valuation lands at $26 on a blended P/E near 12x, the simple excess-return and earnings-yield methods at about $20, the Graham number at $24, and the future-market-cap method at $33 on a high terminal sales multiple. The blended view across the applicable methods is near $24, and the resulting band runs tight from about $20 at the low end to $21 at the base and $21 at the high, with reliability tagged as ok. Today's price sits well above that band, which is why the model-confidence read is flagged high: the implied expectations are above what the methods and the bank's own history typically support.

The honest summary is that this is a high-quality bank trading at a high-quality multiple, and the valuation is rich rather than cheap. The premium is earned by a dozen years of strong returns and clean credit, but the methods are consistent that the price already capitalizes that record. The deciding variable is whether the margin and return hold near their current highs, because the price has little cushion if they normalize.

Catalysts

Q1 2026 was the most recent data point and it extended the trajectory. Net income rose 16.6% to $71.5 million with EPS of $0.50, net interest income reached $134.8 million, and the tax-equivalent margin widened to 3.86% from 3.74% a year earlier. Asset quality stayed pristine, with annualized net charge-offs of 0.02% and nonperforming assets at 0.66% of loans. The next print is the live test of whether the margin can keep expanding or has reached its cyclical ceiling.

The balance sheet trajectory is the other thread. Total assets reached $15.4 billion with loans held for investment of $8.3 billion, so continued loan growth in a still-expanding Texas market is the lever that turns the margin into earnings. Any sign of the margin rolling over, or of credit normalizing off its near-zero loss rate, would matter more to the stock than the headline revenue.

Sentiment is constructive and lately more so. Benchmark initiated coverage on June 25, 2026 with a Buy rating and a $39 target, and the broader analyst average sits near $36 to $39, implying double-digit upside from the low $30s. The bullish case in the coverage rests explicitly on the premium being earned by a long record of high returns and zero credit losses through the 2023 to 2024 regional-bank stress, which is also the record the bear case says is already in the price.

Sources: stocktitan.net (Q1 2026 release), gurufocus.com (Benchmark initiation), sahmcapital.com (FFIN valuation), stockanalysis.com (FFIN forecast).

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive FFIN report on boothcheck